Definitive Healthcare Corp. (NASDAQ:DH) Shares Bought by JPMorgan Chase & Co.

JPMorgan Chase & Co. grew its stake in Definitive Healthcare Corp. (NASDAQ:DH) by 431.7% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 222,090 shares of the company’s stock after purchasing an additional 180,323 shares during the quarter. JPMorgan Chase & Co.’s holdings in Definitive Healthcare were worth $993,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also modified their holdings of DH. Millennium Management LLC purchased a new position in Definitive Healthcare during the second quarter worth about $9,283,000. Massachusetts Financial Services Co. MA raised its position in shares of Definitive Healthcare by 36.8% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 6,053,233 shares of the company’s stock valued at $27,058,000 after buying an additional 1,626,813 shares during the period. 272 Capital LP lifted its holdings in Definitive Healthcare by 74.8% in the third quarter. 272 Capital LP now owns 1,114,080 shares of the company’s stock valued at $4,980,000 after acquiring an additional 476,766 shares during the last quarter. State Street Corp grew its position in Definitive Healthcare by 29.4% in the third quarter. State Street Corp now owns 1,399,729 shares of the company’s stock worth $6,257,000 after acquiring an additional 317,952 shares during the period. Finally, Marshall Wace LLP acquired a new stake in Definitive Healthcare during the second quarter worth $1,535,000. Hedge funds and other institutional investors own 98.67% of the company’s stock.

Insider Activity

In other news, insider William Moschella sold 45,000 shares of the company’s stock in a transaction dated Tuesday, December 3rd. The shares were sold at an average price of $4.70, for a total transaction of $211,500.00. Following the completion of the transaction, the insider now owns 433,830 shares in the company, valued at approximately $2,039,001. This represents a 9.40 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 14.84% of the company’s stock.

Analyst Upgrades and Downgrades

DH has been the topic of several recent analyst reports. Stephens began coverage on shares of Definitive Healthcare in a report on Friday, December 20th. They issued an “equal weight” rating and a $5.00 price objective on the stock. Barclays reaffirmed an “underweight” rating and issued a $4.00 price objective on shares of Definitive Healthcare in a research note on Monday, January 13th. Finally, Needham & Company LLC restated a “hold” rating on shares of Definitive Healthcare in a report on Thursday, January 16th. Two equities research analysts have rated the stock with a sell rating, six have issued a hold rating and three have assigned a buy rating to the company’s stock. According to MarketBeat.com, Definitive Healthcare presently has an average rating of “Hold” and an average price target of $5.72.

Definitive Healthcare Stock Down 0.8 %

Shares of Definitive Healthcare stock opened at $4.83 on Friday. Definitive Healthcare Corp. has a twelve month low of $3.19 and a twelve month high of $10.62. The stock has a market cap of $557.96 million, a price-to-earnings ratio of -1.56, a price-to-earnings-growth ratio of 3.54 and a beta of 1.41. The company has a current ratio of 2.49, a quick ratio of 2.49 and a debt-to-equity ratio of 0.33. The company has a fifty day moving average price of $4.36 and a 200 day moving average price of $4.46.

Definitive Healthcare (NASDAQ:DH) last announced its earnings results on Thursday, November 7th. The company reported $0.05 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.08 by ($0.03). The business had revenue of $62.70 million for the quarter, compared to analysts’ expectations of $61.66 million. Definitive Healthcare had a positive return on equity of 1.76% and a negative net margin of 142.38%. During the same period in the previous year, the firm posted $0.01 earnings per share. Equities research analysts forecast that Definitive Healthcare Corp. will post 0.15 earnings per share for the current fiscal year.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.